- Home
- NXT vs LNTH Comparison
NXT vs LNTH Comparison
Compare NXT & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXT
- LNTH
- Stock Information
- Founded
- NXT 2013
- LNTH 1956
- Country
- NXT United States
- LNTH United States
- Employees
- NXT N/A
- LNTH N/A
- Industry
- NXT Semiconductors
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- NXT Technology
- LNTH Health Care
- Exchange
- NXT Nasdaq
- LNTH Nasdaq
- Market Cap
- NXT 8.5B
- LNTH 7.5B
- IPO Year
- NXT 2023
- LNTH 2015
- Fundamental
- Price
- NXT $56.69
- LNTH $75.56
- Analyst Decision
- NXT Buy
- LNTH Strong Buy
- Analyst Count
- NXT 19
- LNTH 5
- Target Price
- NXT $59.05
- LNTH $133.80
- AVG Volume (30 Days)
- NXT 3.3M
- LNTH 1.5M
- Earning Date
- NXT 05-14-2025
- LNTH 05-07-2025
- Dividend Yield
- NXT N/A
- LNTH N/A
- EPS Growth
- NXT 2.85
- LNTH N/A
- EPS
- NXT 3.47
- LNTH 3.53
- Revenue
- NXT $2,959,197,000.00
- LNTH $1,536,699,000.00
- Revenue This Year
- NXT $9.86
- LNTH $4.63
- Revenue Next Year
- NXT $9.14
- LNTH $9.35
- P/E Ratio
- NXT $16.36
- LNTH $21.40
- Revenue Growth
- NXT 18.38
- LNTH 12.53
- 52 Week Low
- NXT $30.93
- LNTH $73.11
- 52 Week High
- NXT $63.19
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- NXT 65.37
- LNTH 32.65
- Support Level
- NXT $54.87
- LNTH $73.75
- Resistance Level
- NXT $57.39
- LNTH $76.34
- Average True Range (ATR)
- NXT 3.09
- LNTH 2.50
- MACD
- NXT -0.20
- LNTH -0.09
- Stochastic Oscillator
- NXT 55.36
- LNTH 23.36
About NXT Nextracker Inc.
Nextracker (and its subsidiaries) is a leading provider of intelligent, integrated solar tracker and software solutions used in utility-scale and distributed generation solar projects around the world. Nextracker's products enable solar panels in utility-scale power plants to follow the sun's movement across the sky and optimize plant performance. Nextracker has operations in the United States, Mexico, Spain and other countries in Europe, India, Australia, the Middle East, Africa, and Brazil.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.